Ultima-HCG: Compound Profile
Ultima-HCG 5000IU is a lyophilised human chorionic gonadotropin (hCG) preparation manufactured by Ultima Peptides for in-vitro laboratory research applications. This glycoprotein hormone consists of alpha and beta subunits, sharing structural homology with luteinising hormone (LH). Researchers at Stroid UK Shop study hCG for its ability to bind LH/choriogonadotropin receptors and activate adenylyl cyclase signalling cascades in cellular models. The compound exhibits a molecular weight of approximately 36.7 kDa and demonstrates high receptor binding affinity in experimental systems. Laboratory investigations focus on understanding gonadotropin receptor pharmacology and reproductive hormone signal transduction mechanisms.
Laboratory Applications
Research applications of Ultima-HCG 5000IU encompass reproductive endocrinology studies, receptor binding assays, and steroidogenesis pathway investigations. Scientists examine hCG-mediated activation of cAMP signalling in Leydig cell cultures and granulosa cell preparations. The compound serves as a reference standard in competitive binding studies evaluating LH receptor specificity. Researchers investigating post cycle therapy protocols utilise this preparation to study gonadotropin restoration mechanisms following experimental suppression models. Additional research areas include comparative studies with other peptides available through our peptides collection and combination protocols with selective androgen receptor modulators from our SARMs range.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Human Chorionic Gonadotropin |
| Concentration | 5000 International Units |
| Formulation | Lyophilised powder |
| Molecular Weight | ~36.7 kDa |
| Storage Temperature | 2-8°C (refrigerated) |
| Reconstitution | Bacteriostatic water recommended |
| Stability | 24 months unopened |
| Manufacturer | Ultima Peptides |
Research Compliance
Ultima-HCG 5000IU is manufactured exclusively for in-vitro research purposes and laboratory investigation. This product is not intended for human consumption, therapeutic use, or diagnostic applications. Researchers must maintain appropriate laboratory conditions and follow institutional guidelines for peptide hormone handling. All studies should be conducted within approved research facilities with proper biosafety protocols. This compound is restricted to qualified researchers investigating reproductive endocrinology, hormone receptor pharmacology, or related scientific applications.

